ESCRS - Focus on glaucoma management: IOP control and quality of life improvement ;
ESCRS - Focus on glaucoma management: IOP control and quality of life improvement ;

Focus on glaucoma management: IOP control and quality of life improvement

Focus on glaucoma management: IOP control and quality of life improvement
Colin Kerr
Colin Kerr
Published: Thursday, June 8, 2017
Approaches to management for patients with ocular hypertension (OHT) and glaucoma need to be individualised but the goals for all patients remain the same: maintain visual function and quality of life. A panel of experts was convened to discuss strategies for achieving these goals, taking into account evidence-based guideline recommendations and oppportunities for improving safety, effectiveness and treatment adherence with preservative-free and and fixed-combination mechanisms. Download Supplement - click here
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;